A Novel Glycine Receptor Variant with Startle Disease Affects Syndapin I and Glycinergic Inhibition
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
A Novel Glycine Receptor Variant with Startle Disease Affects Syndapin I and Glycinergic Inhibition. / Langlhofer, Georg; Schaefer, Natascha; Maric, Hans M.; Keramidas, Angelo; Zhang, Yan; Baumann, Peter; Blum, Robert; Breitinger, Ulrike; Strømgaard, Kristian; Schlosser, Andreas; Kessels, Michael M.; Koch, Dennis; Qualmann, Britta; Breitinger, Hans Georg; Lynch, Joseph W.; Villmann, Carmen.
I: Journal of Neuroscience, Bind 40, Nr. 25, 2020, s. 4954-4969.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A Novel Glycine Receptor Variant with Startle Disease Affects Syndapin I and Glycinergic Inhibition
AU - Langlhofer, Georg
AU - Schaefer, Natascha
AU - Maric, Hans M.
AU - Keramidas, Angelo
AU - Zhang, Yan
AU - Baumann, Peter
AU - Blum, Robert
AU - Breitinger, Ulrike
AU - Strømgaard, Kristian
AU - Schlosser, Andreas
AU - Kessels, Michael M.
AU - Koch, Dennis
AU - Qualmann, Britta
AU - Breitinger, Hans Georg
AU - Lynch, Joseph W.
AU - Villmann, Carmen
N1 - Publisher Copyright: Copyright © 2020 the authors
PY - 2020
Y1 - 2020
N2 - Glycine receptors (GlyRs) are the major mediators of fast synaptic inhibition in the adult human spinal cord and brainstem. Hereditary mutations to GlyRs can lead to the rare, but potentially fatal, neuromotor disorder hyperekplexia. Most mutations located in the large intracellular domain (TM3-4 loop) of the GlyRa1 impair surface expression levels of the receptors. The novel GLRA1 mutation P366L, located in the TM3-4 loop, showed normal surface expression but reduced chloride currents, and accelerated whole-cell desensitization observed in whole-cell recordings. At the single-channel level, we observed reduced unitary conductance accompanied by spontaneous opening events in the absence of extracellular glycine. Using peptide microarrays and tandem MS-based analysis methods, we show that the proline-rich stretch surrounding P366 mediates binding to syndapin I, an F-BAR domain protein involved in membrane remodeling. The disruption of the noncanonical Src homology 3 recognition motif by P366L reduces syndapin I binding. These data suggest that the GlyRa1 subunit interacts with intracellular binding partners and may therefore play a role in receptor trafficking or synaptic anchoring, a function thus far only ascribed to the GlyRb subunit. Hence, the P366L GlyRa1 variant exhibits a unique set of properties that cumulatively affect GlyR functionality and thus might explain the neuropathological mechanism underlying hyperekplexia in the mutant carriers. P366L is the first dominant GLRA1 mutation identified within the GlyRa1 TM3-4 loop that affects GlyR physiology without altering protein expression at the whole-cell and surface levels.
AB - Glycine receptors (GlyRs) are the major mediators of fast synaptic inhibition in the adult human spinal cord and brainstem. Hereditary mutations to GlyRs can lead to the rare, but potentially fatal, neuromotor disorder hyperekplexia. Most mutations located in the large intracellular domain (TM3-4 loop) of the GlyRa1 impair surface expression levels of the receptors. The novel GLRA1 mutation P366L, located in the TM3-4 loop, showed normal surface expression but reduced chloride currents, and accelerated whole-cell desensitization observed in whole-cell recordings. At the single-channel level, we observed reduced unitary conductance accompanied by spontaneous opening events in the absence of extracellular glycine. Using peptide microarrays and tandem MS-based analysis methods, we show that the proline-rich stretch surrounding P366 mediates binding to syndapin I, an F-BAR domain protein involved in membrane remodeling. The disruption of the noncanonical Src homology 3 recognition motif by P366L reduces syndapin I binding. These data suggest that the GlyRa1 subunit interacts with intracellular binding partners and may therefore play a role in receptor trafficking or synaptic anchoring, a function thus far only ascribed to the GlyRb subunit. Hence, the P366L GlyRa1 variant exhibits a unique set of properties that cumulatively affect GlyR functionality and thus might explain the neuropathological mechanism underlying hyperekplexia in the mutant carriers. P366L is the first dominant GLRA1 mutation identified within the GlyRa1 TM3-4 loop that affects GlyR physiology without altering protein expression at the whole-cell and surface levels.
KW - Glycine receptor
KW - Hyperekplexia
KW - PPII helix
KW - Syndapin I
KW - TM3-4 loop
U2 - 10.1523/JNEUROSCI.2490-19.2020
DO - 10.1523/JNEUROSCI.2490-19.2020
M3 - Journal article
C2 - 32354853
AN - SCOPUS:85086747495
VL - 40
SP - 4954
EP - 4969
JO - The Journal of neuroscience : the official journal of the Society for Neuroscience
JF - The Journal of neuroscience : the official journal of the Society for Neuroscience
SN - 0270-6474
IS - 25
ER -
ID: 271634094